Pordy: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

51

Anti-Anginal and Anti-Ischemic Effects of Mibefradil, a New T-Type Calcium Channel Antagonist

Kobrin, Isaac, Bieska, Gabriele, Charlon, Vincent, Lindberg, Elisabet, Pordy, Robert

Journal:

Year:

1998

Language:

english

File:

PDF, 369 KB

english, 1998

52

The "Two-Step" Exercise Electrocardiogram in Functional Heart Disturbances and in Organic Heart Disease: The Use of Ergotamine Tartrate

MASTER, A. M., PORDY, L., KOLKER, J., BLUMENTHAL, M. J.

Journal:

Year:

1950

Language:

english

File:

PDF, 2.26 MB

english, 1950

53

Hangover free! The social and material trajectories of PartySmart

Pordié, Laurent

Journal:

Anthropology & Medicine

Year:

2015

Language:

english

File:

PDF, 140 KB

english, 2015

54

Unipolar Bronchial Electrocardiographic Exploration of the Heart in Man: A Preliminary Report

GOLDSTEIN, I., PORDY, L., CHESKY, K., ARAI, H. S., SNYDER, E. R., FEUERSTEIN, S.

Journal:

Year:

1951

Language:

english

File:

PDF, 4.44 MB

english, 1951

55

ODYSSEY FH I and FH II: 78 week results with alirocumab treatment in 735 patients with heterozygous familial hypercholesterolaemia

J. J. Kastelein, H. N. Ginsberg, G. Langslet, G. K. Hovingh, R. Ceska, R. Dufour, D. Blom, F. Civeira, M. Krempf, C. Lorenzato, J. Zhao, R. Pordy, M. T. Baccara-dinet, D. A. Gipe, M. J. Geiger, M. Far

Year:

2015

Language:

english

File:

PDF, 330 KB

english, 2015

56

Efficacy and safety of the proprotein convertase subtilisin/kexin type 9 inhibitor alirocumab among high cardiovascular risk patients on maximally tolerated statin therapy: The ODYSSEY COMBO I study

Kereiakes, Dean J., Robinson, Jennifer G., Cannon, Christopher P., Lorenzato, Christelle, Pordy, Robert, Chaudhari, Umesh, Colhoun, Helen M.

Journal:

American Heart Journal

Year:

2015

Language:

english

File:

PDF, 1.16 MB

english, 2015

57

Alirocumab Versus Ezetimibe Over 104 Weeks In Individuals With Hypercholesterolemia And High Cardiovascular Risk: Final Results From ODYSSEY COMBO II

El Shahawy, Mahfouz, Cannon, Christopher, Blom, Dirk, McKenney, James, Cariou, Bertrand, Lecorps, Guillaume, Pordy, Robert, Chaudhari, Umesh, Colhoun, Helen

Journal:

Journal of Clinical Lipidology

Year:

2016

Language:

english

File:

PDF, 356 KB

english, 2016

58

Cardiac Diagnostic Methods in Coronary Artery Disease: Electrocardiogram, “2-Step” Exercise Test and Ballistocardiogram

Journal:

Year:

1955

Language:

english

File:

PDF, 3.78 MB

english, 1955

59

Inverse Relationship Between Major Adverse Cardiovascular Events and non-High-Density Lipoprotein Cholesterol and Apolipoprotein B in Phase 3 Trials of Alirocumab

Davidson, Michael H., Cannon, Christopher P., Ginsberg, Henry N., Pordy, Robert, Bessac, Laurence, Minini, Pascal, Eckel, Robert H., Ray, Kausik K.

Journal:

Journal of Clinical Lipidology

Year:

2016

Language:

english

File:

PDF, 143 KB

english, 2016

60

Alirocumab Treatment Effect on Non-HDL-C: Pooled Analyses of 10 Phase 3 Trials in the ODYSSEY Program

Bays, Harold E., Leiter, Lawrence A., Colhoun, Helen M., Thompson, Desmond, Bessac, Laurence, Pordy, Robert, Toth, Peter P.

Journal:

Journal of Clinical Lipidology

Year:

2015

Language:

english

File:

PDF, 257 KB

english, 2015

61

Chest Pain—Cardiac vs. Noncardiac

Master, A.M., Jaffe, H.L., Pordy, L.

Journal:

Medical Clinics of North America

Year:

1954

Language:

english

File:

PDF, 1.78 MB

english, 1954

62

Geothermal activity in the subglacial Katla caldera, Iceland, 1999–2005, studied with radar altimetry

Guđmundsson, Magnús T., Höganadóttir, Pórdís, Kristinsson, Arnór Bergur, Guđbjörnsson, Snaebjörn

Journal:

Annals of Glaciology

Year:

2007

Language:

english

File:

PDF, 505 KB

english, 2007

63

RELATIONSHIP BETWEEN MAJOR ADVERSE CARDIOVASCULAR EVENTS AND ACHIEVED LOW-DENSITY LIPOPROTEIN CHOLESTEROL LEVELS IN PHASE 3 ODYSSEY TRIALS OF ALIROCUMAB VERSUS CONTROL

Cannon, Christopher P., Ginsberg, Henry, Ray, Kausik, Davidson, Michael, Pordy, Robert, Bessac, Laurence, Minini, Pascal, Eckel, Robert

Journal:

Journal of the American College of Cardiology

Year:

2016

Language:

english

File:

PDF, 649 KB

english, 2016

64

Clinical Ballistocardiography

Pordy, Leon, Chesky, Kenneth, Moser, Marvin, Taymor, Robert C., Master, Arthur M., Storch, Sidney

Journal:

Postgraduate Medicine

Year:

1952

Language:

english

File:

PDF, 970 KB

english, 1952

65

No effect of PCSK9 inhibitor alirocumab on the incidence of diabetes in a pooled analysis from 10 ODYSSEY Phase 3 studies

Colhoun, Helen M., Ginsberg, Henry N., Robinson, Jennifer G., Leiter, Lawrence A., Müller-Wieland, Dirk, Henry, Robert R., Cariou, Bertrand, Baccara-Dinet, Marie T., Pordy, Robert, Merlet, Laurence, E

Journal:

European Heart Journal

Year:

2016

Language:

english

File:

PDF, 502 KB

english, 2016

66

Efficacy and Safety of Alirocumab in Patients with Heterozygous Familial Hypercholesterolemia and LDL-C of 160 mg/dl or Higher

Ginsberg, Henry N., Rader, Daniel J., Raal, Frederick J., Guyton, John R., Baccara-Dinet, Marie T., Lorenzato, Christelle, Pordy, Robert, Stroes, Erik

Journal:

Cardiovascular Drugs and Therapy

Year:

2016

Language:

english

File:

PDF, 593 KB

english, 2016

67

Safety and efficacy of evinacumab, a monoclonal antibody to ANGPTL3, in patients with homozygous familial hypercholesterolemia receiving concomitant lipid-lowering therapies

Gaudet, Daniel, Gipe, Daniel A., Pordy, Robert, Sasiela, William, Chan, Kuo-Chen, Khoury, Etienne

Journal:

Journal of Clinical Lipidology

Year:

2016

Language:

english

File:

PDF, 43 KB

english, 2016

68

Safety of Alirocumab (A PCSK9 Monoclonal Antibody) from 14 Randomized Trials

Jones, Peter H., Bays, Harold E., Chaudhari, Umesh, Pordy, Robert, Lorenzato, Christelle, Miller, Kathryn, Robinson, Jennifer G.

Journal:

The American Journal of Cardiology

Year:

2016

Language:

english

File:

PDF, 839 KB

english, 2016

69

Safety and efficacy of evinacumab, a monoclonal antibody to ANGPTL3, in patients with homozygous familial hypercholesterolemia: A single-arm, open-label, proof-of-concept study

Gaudet, D., Gipe, D.A., Khoury, É., Pordy, R., Sasiela, W., Chan, K.C.

Journal:

Atherosclerosis

Year:

2016

Language:

english

File:

PDF, 176 KB

english, 2016

70

Pharmacodynamic relationship between PCSK9, alirocumab, and LDL-C lowering in four phase 3 odyssey trials with/without statin background

Robinson, J.G., Farnier, M., Kastelein, J.J., Roth, E.M., Taskinen, M.R., Colhoun, H.M., Brunet, A., DiCioccio, A.T., Lecorps, G., Pordy, R., Baccara-Dinet, M.T., Cannon, C.P.

Journal:

Atherosclerosis

Year:

2016

Language:

english

File:

PDF, 214 KB

english, 2016

71

RELATIONSHIP BETWEEN PERCENTAGE REDUCTION IN LOW-DENSITY LIPOPROTEIN CHOLESTEROL LEVELS AND MAJOR ATHEROSCLEROTIC CARDIOVASCULAR DISEASE AMONG PATIENTS TREATED WITH STATINS +/- ALIROCUMAB OR EZETIMIBE IN THE PHASE 3 ODYSSEY TRIALS

Ray, Kausik, Ginsberg, Henry, Davidson, Michael, Pordy, Robert, Bessac, Laurence, Minini, Pascal, Eckel, Robert, Cannon, Christopher

Journal:

Journal of the American College of Cardiology

Year:

2016

Language:

english

File:

PDF, 474 KB

english, 2016

72

Reductions in Atherogenic Lipids and Major Cardiovascular Events: A Pooled Analysis of 10 ODYSSEY Trials Comparing Alirocumab to Control

Ray, Kausik K., Ginsberg, Henry N., Davidson, Michael H., Pordy, Robert, Bessac, Laurence, Minini, Pascal, Eckel, Robert H., Cannon, Christopher P.

Journal:

Year:

2016

Language:

english

File:

PDF, 2.40 MB

english, 2016

73

Open-label therapy with alirocumab in patients with heterozygous familial hypercholesterolemia: Results from three years of treatment

Dufour, Robert, Bergeron, Jean, Gaudet, Daniel, Weiss, Robert, Hovingh, G. Kees, Qing, Zhizhi, Yang, Feng, Andisik, Matthew, Torri, Albert, Pordy, Robert, Gipe, Daniel A.

Journal:

International Journal of Cardiology

Year:

2017

Language:

english

File:

PDF, 1.08 MB

english, 2017

74

Brain Anatomy: Thoughts From the Inside

Pordy, William T.

Journal:

Annals of Internal Medicine

Year:

2016

Language:

english

File:

PDF, 29 KB

english, 2016

75

LOWER ON-TREATMENT LOW-DENSITY LIPOPROTEIN CHOLESTEROL IS ASSOCIATED WITH LOWER CARDIOVASCULAR RISK IN VERY HIGH RISK PATIENTS WITH ATHEROSCLEROTIC CARDIOVASCULAR DISEASE: ANALYSES FROM THE ODYSSEY TRIALS

Ray, Kausik Kumar, Vallejo-Vaz, Antonio, Ginsberg, Henry, Davidson, Michael, Eckel, Robert H., Lee, Veronica, Bessac, Laurence, Pordy, Robert, Letierce, Alexia, Cannon, Christopher

Journal:

Journal of the American College of Cardiology

Year:

2017

Language:

english

File:

PDF, 1.16 MB

english, 2017

76

LOWER ON-TREATMENT LOW-DENSITY LIPOPROTEIN CHOLESTEROL IS ASSOCIATED WITH LOWER CARDIOVASCULAR RISK IN WOMEN: ANALYSES FROM THE ODYSSEY TRIALS OF ALIROCUMAB VERSUS CONTROL

Vallejo-Vaz, Antonio, Ginsberg, Henry, Davidson, Michael, Eckel, Robert H., Cannon, Christopher, Lee, Veronica, Bessac, Laurence, Pordy, Robert, Letierce, Alexia, Ray, Kausik

Journal:

Journal of the American College of Cardiology

Year:

2017

Language:

english

File:

PDF, 876 KB

english, 2017

77

USE OF HIGH-INTENSITY STATIN THERAPY POST-ACUTE CORONARY SYNDROME IN THE ONGOING ODYSSEY OUTCOMES TRIAL OF ALIROCUMAB, A PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 MONOCLONAL ANTIBODY, VERSUS PLACEBO: INTERIM BASELINE DATA

Goodman, Shaun G., Schwartz, Gregory, Bhatt, Deepak L., Bittner, Vera, Diaz, Rafael, Hanotin, Corinne, Harrington, Robert, Jukema, Johan, Moryusef, Angele, Pordy, Robert, Roe, Matthew, Sasiela, Willia

Journal:

Journal of the American College of Cardiology

Year:

2017

Language:

english

File:

PDF, 381 KB

english, 2017

78

Safety and Efficacy of Evinacumab, A Monoclonal Antibody to ANGPTL3, In Homozygous Familial Hypercholesterolemia

Gaudet, Daniel, Gipe, Daniel, Hovingh, Kees, Ahmad, Zahid, Cuchel, Marina, Shah, Prediman, Chyu, Kuang-Yuh, Pordy, Robert, Sasiela, William, Chan, Kuo-Chen, Khoury, Etienne

Journal:

Journal of Clinical Lipidology

Year:

2017

Language:

english

File:

PDF, 217 KB

english, 2017

79

Efficacy and Safety of Alirocumab Versus Ezetimibe Over 2 Years (from ODYSSEY COMBO II)

El Shahawy, Mahfouz, Cannon, Christopher P., Blom, Dirk J., McKenney, James M., Cariou, Bertrand, Lecorps, Guillaume, Pordy, Robert, Chaudhari, Umesh, Colhoun, Helen M.

Journal:

The American Journal of Cardiology

Year:

2017

Language:

english

File:

PDF, 1.83 MB

english, 2017

80

ANGPTL3 Inhibition in Homozygous Familial Hypercholesterolemia

Gaudet, Daniel, Gipe, Daniel A., Pordy, Robert, Ahmad, Zahid, Cuchel, Marina, Shah, Prediman K., Chyu, Kuang-Yuh, Sasiela, William J., Chan, Kuo-Chen, Brisson, Diane, Khoury, Etienne, Banerjee, Poulab

Journal:

New England Journal of Medicine

Year:

2017

Language:

english

File:

PDF, 73 KB

english, 2017

81

Use of High-Intensity Statin Therapy Post-Acute Coronary Syndrome in the Ongoing ODYSSEY OUTCOMES Trial of Alirocumab, A Proprotein Convertase Subtilisin/Kexin type 9 Monoclonal Antibody, Versus Placebo: Interim Baseline Data

White, H., Goodman, S., Schwartz, G., Bhatt, D., Bittner, V., Diaz, R., Hanotin, C., Harrington, R., Jukema, J., Moryusef, A., Pordy, R., Roe, M., Sasiela, W., Szarek, M., Tamby, J., Zeiher, A., Steg,

Journal:

Heart Lung & Circulation

Year:

2017

Language:

english

File:

PDF, 57 KB

english, 2017

82

Alirocumab Treatment and Achievement of Non‐High‐Density Lipoprotein Cholesterol and Apolipoprotein B Goals in Patients With Hypercholesterolemia: Pooled Results From 10 Phase 3 ODYSSEY Trials

Bays, Harold E., Leiter, Lawrence A., Colhoun, Helen M., Thompson, Desmond, Bessac, Laurence, Pordy, Robert, Toth, Peter P.

Journal:

Journal of the American Heart Association

Year:

2017

Language:

english

File:

PDF, 2.53 MB

english, 2017

83

Safety and efficacy of evinacumab, a monoclonal antibody to ANGPTL3, in patients with homozygous familial hypercholesterolemia: a single-arm, open-label, proof-of-concept study

Gaudet, Daniel, Gipe, Daniel, Hovingh, Kees, Ahmad, Zahid, Cuchel, Marina, Shah, Prediman, Chyu, Kuang -Yuh, Pordy, Robert, Sasiela, William, Chan, Kuo -Chen, Khoury, Etienne

Journal:

Atherosclerosis

Year:

2017

Language:

english

File:

PDF, 53 KB

english, 2017

84

Congenital Dextrocardia with Situs Inversus Complicated by Hypertension and Angina Pectoris

Master, Arthur M., Pordy, Leon, Aral, Harold S.

Journal:

Year:

1950

Language:

english

File:

PDF, 1.23 MB

english, 1950

85

Regulation Multiple: Pharmaceutical Trajectories and Modes of Control in the ASEAN

Quet, Mathieu, Pordié, Laurent, Bochaton, Audrey, Chantavanich, Supang, Kiatying-Angsulee, Niyada, Lamy, Marie, Vungsiriphisal, Premjai

Journal:

Science Technology & Society

Year:

2018

Language:

english

File:

PDF, 690 KB

english, 2018

86

Cardiovascular Outcomes With Alirocumab After Acute Coronary Syndrome: Results of the Odyssey Outcomes Trial

White, H., Steg, P., Szarek, M., Bhatt, D., Bittner, V., Diaz, R., Edelberg, J., Goodman, S., Hantoin, C., Harrington, R., Jukema, J., Lecorps, G., Moryusef, A., Pordy, R., Roe, M., Zeiher, A., Schwar

Journal:

Heart, Lung and Circulation

Year:

2018

Language:

english

File:

PDF, 128 KB

english, 2018

87

5938Efficacy of evinacumab in homozygous familial hypercholesterolemia patients with null or non-null LDL-receptor mutations and on various background therapies

Hovingh, G.K., Gipe, D.A., Ahmad, Z., Cuchel, M., Shah, P., Chyu, K.Y., Pordy, R., Sasiela, W.J., Chan, K.C., Khoury, E., Gaudet, D.

Journal:

European Heart Journal

Year:

2017

Language:

english

File:

PDF, 337 KB

english, 2017

88

Lower On‐Treatment Low‐Density Lipoprotein Cholesterol and Major Adverse Cardiovascular Events in Women and Men: Pooled Analysis of 10 ODYSSEY Phase 3 Alirocumab Trials

Vallejo‐Vaz, Antonio J., Ginsberg, Henry N., Davidson, Michael H., Eckel, Robert H., Cannon, Christopher P., Lee, L. Veronica, Bessac, Laurence, Pordy, Robert, Letierce, Alexia, Ray, Kausik K.

Journal:

Journal of the American Heart Association

Year:

2018

Language:

english

File:

PDF, 1.67 MB

english, 2018

89

Cilazapril with Adjunctive Hydrochlorothiazide

Pordy, Robert C.

Journal:

Year:

1995

Language:

english

File:

PDF, 1.45 MB

english, 1995

90

Inhibition of Angiopoietin-Like Protein 3 With a Monoclonal Antibody Reduces Triglycerides in Hypertriglyceridemia

Ahmad, Zahid, Banerjee, Poulabi, Hamon, Sara, Chan, Kuo-Chen, Bouzelmat, Aurelie, Sasiela, Willliam J., Pordy, Robert, Mellis, Scott, Dansky, Hayes, Gipe, Daniel A., Dunbar, Richard L.

Journal:

Year:

2019

Language:

english

File:

PDF, 3.39 MB

english, 2019

91

Associations between lower levels of low-density lipoprotein cholesterol and cardiovascular events in very high-risk patients: Pooled analysis of nine ODYSSEY trials of alirocumab versus control

Vallejo-Vaz, Antonio J., Ray, Kausik K., Ginsberg, Henry N., Davidson, Michael H., Eckel, Robert H., Veronica Lee, L., Bessac, Laurence, Pordy, Robert, Letierce, Alexia, Cannon, Christopher P.

Journal:

Atherosclerosis

Year:

2019

Language:

english

File:

PDF, 1.87 MB

english, 2019

92

Functional Analysis of LDLR (Low-Density Lipoprotein Receptor) Variants in Patient Lymphocytes to Assess the Effect of Evinacumab in Homozygous Familial Hypercholesterolemia Patients With a Spectrum of LDLR Activity

Banerjee, Poulabi, Chan, Kuo-Chen, Tarabocchia, Michel, Benito-Vicente, Asier, Alves, Ana C., Uribe, Kepa B., Bourbon, Mafalda, Skiba, Paul J., Pordy, Robert, Gipe, Daniel A., Gaudet, Daniel, Martin,

Journal:

Arteriosclerosis Thrombosis and Vascular Biology

Year:

2019

Language:

english

File:

PDF, 1.92 MB

english, 2019

93

Functional Analysis of LDLR (Low-Density Lipoprotein Receptor) Variants in Patient Lymphocytes to Assess the Effect of Evinacumab in Homozygous Familial Hypercholesterolemia Patients With a Spectrum of LDLR Activity

Banerjee, Poulabi, Chan, Kuo-Chen, Tarabocchia, Michel, Benito-Vicente, Asier, Alves, Ana C., Uribe, Kepa B., Bourbon, Mafalda, Skiba, Paul J., Pordy, Robert, Gipe, Daniel A., Gaudet, Daniel, Martin,

Journal:

Arteriosclerosis Thrombosis and Vascular Biology

Year:

2019

File:

PDF, 1.92 MB

2019

94

P1226Very low achieved low-density lipoprotein cholesterol level with alirocumab treatment after acute coronary syndrome: ODYSSEY OUTCOMES

Schwartz, G, Szarek, M, Li, Q H, Chiang, C E, Diaz, R, Hagstrom, E, Huo, Y, Jukema, J W, Lecorps, G, Moryusef, A, Pordy, R, White, H D, Yusoff, K, Zeiher, A M, Steg, P G

Journal:

European Heart Journal

Year:

2019

Language:

english

File:

PDF, 109 KB

english, 2019

95

P1226Very low achieved low-density lipoprotein cholesterol level with alirocumab treatment after acute coronary syndrome: ODYSSEY OUTCOMES

Schwartz, G, Szarek, M, Li, Q H, Chiang, C E, Diaz, R, Hagstrom, E, Huo, Y, Jukema, J W, Lecorps, G, Moryusef, A, Pordy, R, White, H D, Yusoff, K, Zeiher, A M, Steg, P G

Journal:

European Heart Journal

Year:

2019

File:

PDF, 109 KB

2019

96

4115Effect of alirocumab on recurrent cardiovascular events after acute coronary syndrome, according to the intensity of background statin treatment

Diaz, R, Li, Q H, Bhatt, D L, Bittner, V A, Baccara-Dinet, M T, Goodman, S G, Jukema, J W, Parkhomenko, A, Pordy, R, Reiner, Z, Szarek, M, Tse, H F, Zeiher, A M, Schwartz, G G, Steg, P G

Journal:

European Heart Journal

Year:

2019

Language:

english

File:

PDF, 97 KB

english, 2019

97

Peripheral Artery Disease and Venous Thromboembolic Events After Acute Coronary Syndrome: Role of Lipoprotein(a) and Modification by Alirocumab: Prespecified Analysis of a Randomized Clinical Trial

Schwartz, Gregory G., Steg, Ph. Gabriel, Szarek, Michael, Bittner, Vera A., Diaz, Rafael, Goodman, Shaun G., Kim, Yong-Un, Jukema, J. Wouter, Pordy, Robert, Roe, Matthew T., White, Harvey D., Bhatt, D

Journal:

Year:

2020

Language:

english

File:

PDF, 3.63 MB

english, 2020

98

Efficacy and Safety of Alirocumab inÂ Adults With Homozygous FamilialÂ Hypercholesterolemia

Blom, Dirk J., Harada-Shiba, Mariko, Rubba, Paolo, Gaudet, Daniel, Kastelein, John J.P., Charng, Min-Ji, Pordy, Robert, Donahue, Stephen, Ali, Shazia, Dong, Yuping, Khilla, Nagwa, Banerjee, Poulabi, B

Journal:

Journal of the American College of Cardiology

Year:

2020

File:

PDF, 595 KB

2020

99

Intensity of statin treatment after acute coronary syndrome, residual risk, and its modification by alirocumab: insights from the ODYSSEY OUTCOMES trial

Diaz, Rafael, Li, Qian H, Bhatt, Deepak L, Bittner, Vera A, Baccara-Dinet, Marie T, Goodman, Shaun G, Jukema, J Wouter, Kimura, Takeshi, Parkhomenko, Alexander, Pordy, Robert, Reiner, Å½eljko, Roe, Ma

Journal:

European Journal of Preventive Cardiology

Year:

2020

File:

PDF, 423 KB

2020

100

Effect of alirocumab on major adverse cardiovascular events according to renal function in patients with a recent acute coronary syndrome: prespecified analysis from the ODYSSEY OUTCOMES randomized clinical trial

TuÃ±Ã³n, JosÃ©, Steg, Philippe Gabriel, Bhatt, Deepak L, Bittner, Vera A, DÃaz, Rafael, Goodman, Shaun G, Jukema, J Wouter, Kim, Yong-Un, Li, Qian H, Mueller, Christian, Parkhomenko, Alexander, Pordy

Journal:

European Heart Journal

Year:

2020

File:

PDF, 947 KB

2020